Plus Therapeutics, Inc.

NasdaqCM:PSTV Stock Report

Market Cap: US$7.1m

Plus Therapeutics Balance Sheet Health

Financial Health criteria checks 0/6

Plus Therapeutics has a total shareholder equity of $-5.2M and total debt of $3.3M, which brings its debt-to-equity ratio to -63.6%. Its total assets and total liabilities are $7.0M and $12.2M respectively.

Key information

-63.6%

Debt to equity ratio

US$3.29m

Debt

Interest coverage ration/a
CashUS$4.79m
Equity-US$5.17m
Total liabilitiesUS$12.15m
Total assetsUS$6.98m

Recent financial health updates

Recent updates

Plus Therapeutics jumps 18% as JonesTrading adds another Buy rating

Oct 07

Plus Therapeutics finalizes $17.6M grant from Texas, to get initial funds by October end

Sep 22

Plus Therapeutics GAAP EPS of -$0.24 misses by $0.02

Jul 21

Financial Position Analysis

Short Term Liabilities: PSTV has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: PSTV has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: PSTV has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: PSTV's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: PSTV has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: PSTV has less than a year of cash runway if free cash flow continues to reduce at historical rates of 7.1% each year


Discover healthy companies